TET2 and glioblastoma: Quantitative RT-PCR analysis of a panel of low-passage patient-derived primary GBM neurospheres enriched for GSCs revealed very low TET2 expression relative to non-neoplastic glial progenitor cells (GPCs) (Fig. 1).